ARCT - Arcturus Therapeutics GAAP EPS of -$0.82 beats by $1.04 revenue of $27.09M beats by $24.58M
- Arcturus Therapeutics press release ( NASDAQ: ARCT ): Q2 GAAP EPS of -$0.82 beats by $1.04 .
- Revenue of $27.09M (+1254.5% Y/Y) beats by $24.58M .
- Company’s cash balance totaled $283.5 million as of June 30, 2022, compared to a cash balance of $370.5 million at December 31, 2021.
For further details see:
Arcturus Therapeutics GAAP EPS of -$0.82 beats by $1.04, revenue of $27.09M beats by $24.58M